Literature DB >> 11796575

Influence of parasite load on the ability of type 1 T cells to control Leishmania major infection.

Brian Hondowicz1, Phillip Scott.   

Abstract

BALB/c mice infected with Leishmania major developed a type 2 immune response which failed to control parasite replication. We found that scid mice that received splenocytes from BALB/c mice that had been infected for 3 weeks with L. major (a type 2 cell population) and that were subsequently infected with L. major were protected when they were treated with interleukin 12 (IL-12). In contrast, IL-12 was ineffective at protecting BALB/c mice infected for 3 weeks, suggesting that a high parasite load regulates the development of protective immunity. To determine how this regulation operates, we performed a series of adoptive transfers of naïve, type 1 or type 2 splenocytes into scid mice. The recipient scid mice were infected either for 5 weeks prior to cell transfer (and thus had a high parasite load) or at the time of cell transfer. scid mice that were infected for 5 weeks and received a type 1 cell population were able to cure their lesions. However, when 5-week-infected scid mice received both type 1 and 2 cell populations, they were unable to control their infections. In contrast, the same type 1 and 2 cells transferred to naïve scid mice, which were subsequently infected, provided protection. In addition, we found that naïve cells mediated protection in scid mice with established lesions. These results show that high parasite numbers do not block type 1 protective responses or the development of type 1 responses. Instead, the influence of a high parasite load is dependent on the presence of a type 2 cell population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796575      PMCID: PMC127658          DOI: 10.1128/IAI.70.2.498-503.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Role of T cell subsets during the recall of immunologic memory to Leishmania major.

Authors:  I Müller
Journal:  Eur J Immunol       Date:  1992-12       Impact factor: 5.532

2.  Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.

Authors:  P A Bretscher; G Wei; J N Menon; H Bielefeldt-Ohmann
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

3.  A role for Lyt-2+ T cells in resistance to cutaneous leishmaniasis in immunized mice.

Authors:  J P Farrell; I Muller; J A Louis
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

4.  Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.

Authors:  M Barral-Netto; A Barral; C E Brownell; Y A Skeiky; L R Ellingsworth; D R Twardzik; S G Reed
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

5.  The role of IL-10 in promoting disease progression in leishmaniasis.

Authors:  M M Kane; D M Mosser
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

6.  Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis.

Authors:  A Barral; M Barral-Netto; E C Yong; C E Brownell; D R Twardzik; S G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

7.  Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection.

Authors:  K Varkila; R Chatelain; L M Leal; R L Coffman
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

8.  Resistance to cutaneous leishmaniasis in nude mice injected with L3T4+ T cells but not with Ly-2+ T cells.

Authors:  H Moll; R Scollay; G F Mitchell
Journal:  Immunol Cell Biol       Date:  1988-02       Impact factor: 5.126

9.  Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines.

Authors:  B J Holaday; M D Sadick; Z E Wang; S L Reiner; F P Heinzel; T G Parslow; R M Locksley
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

10.  Recombinant interleukin 12 cures mice infected with Leishmania major.

Authors:  F P Heinzel; D S Schoenhaut; R M Rerko; L E Rosser; M K Gately
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more
  1 in total

1.  Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid.

Authors:  Karina Corware; Debra Harris; Ian Teo; Matthew Rogers; Kikkeri Naresh; Ingrid Müller; Sunil Shaunak
Journal:  Biomaterials       Date:  2011-07-31       Impact factor: 12.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.